Suberoyl bis-hydroxamic Acid CAS: 38937-66-5
MF: C8H16N2O4
MW: 204.22
Inhibits histone deacetylation.

Suberoyl bis-hydroxamic Acid (CAS 38937-66-5)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 118ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
5
1
4
0
3
0
2
0
1
0
Sinonimo: suberic bishydroxamate
Applicazione: Inhibits histone deacetylation
Numero CAS: 38937-66-5
Purezza: ≥98%
Peso molecolare: 204.22
Formula molecolare: C8H16N2O4
* Vedere Certificato di Analisi per informazioni sul lotto specifico (incluso il contenuto d'acqua).
Invia una review per questo prodotto e ricevi 15 Cruz Credits

Suberoyl bis-hydroxamic Acid, an HDAC (histone deacetylase) inhibitor, inhibits HDAC1 (ID50 = 0.25 μM) and HDAC3 (ID50 = 0.3 μM). Suberoyl bis-hydroxamic Acid has been shown to induce differentiation of certain murine cells via blocking of HEXIM1 (hexamethylene bisacetamide) activity. Other experiments have shown Suberoyl bis-hydroxamic Acid to induce apoptosis in proliferative cells via induction of P21, P53, PUMA, and Bax gene expression. Additionally, the compound has been noted to activate Notch 1 signaling, which is associated with antiproliferative and apoptotic effects in certain medullary cells. Additional proteins induced by Suberoyl bis-hydroxamic Acid include caspase-3, poly ADP-ribose polymerase, Bcl-X(L), and Bad whose effects range from cellular growth, senescence and apoptosis.


Referenze

1. Preston, C.M. and McFarlane, M. 1998. Virology. 249: 418-426. PMID: 9791032
2. Zhuang, Z.G., et al. 2008. Acta Pharmacol. Sin. 29: 1459-1466. PMID: 19026165
3. Ning, L., et al. 2008. Oncologist. 13: 98-104. PMID: 18305053
4. Flis, S., et al. 2009. Biochem. Biophys. Res. Commun. 387: 336-341. PMID: 19596269

Stato fisico :
Solid
Solubilità :
Soluble in DMSO (~1.3 mg/ml), DMF (~0.1 mg/ml), and a 1:10 solution of DMSO:PBS(pH7.2) (~0.1 mg/ml).
CONSERVAZIONE :
Store at room temperature
Punto di scioglimento :
153-155° C (lit.)
Punto di ebollizione :
491.62° C (Predicted)
Densità :
1.22 g/cm3
Indice di rifrazione :
n20D 1.50
IC50 :
HDAC1: IC50 = 0.25 µM; HDAC3: IC50 = 0.30 µM; the growth of proliferating keratinocytes : IC50 = 11.57 µM; the growth of squamous cell carcinoma cells: IC50 = 5.39 µM; HT-29 (Colon adenocarcinoma cells): EC5050 = 32000 nM (Homo sapiens); SK-BR-3 (Breast adenocarcinoma): EC5050 = 27000 nM (Homo sapiens); Plasmodium falciparum: IC50 = 1530 nM (Plasmodium falciparum); Histone deacetylase HD2: IC50 = 320 nM (Zea mays); Histone deacetylase 2: IC50 = 1150 nM (Rattus norvegicus)
Ki Data :
Histone deacetylase 3: Ki= 125 nM (Homo sapiens); Histone deacetylase 5: Ki= 9500 nM (Homo sapiens); Histone deacetylase 6: Ki= 14.5 nM (Homo sapiens); Histone deacetylase 2: Ki= 29 nM (Homo sapiens); Histone deacetylase 8: Ki= 950 nM (Homo sapiens); Histone deacetylase 1: Ki= 19 nM (Homo sapiens)
Valori pK :
pKa: 9.18
Solo per uso in Ricerca. Non previsto per Uso Diagnostico o Terapeutico.
WGK Germania :
3
PubChem CID :
5173
Numero MDL :
MFCD00192455
SMILES :
C(CCCC(=O)NO)CCC(=O)NO

Download SDS (MSDS)

CERTIFICATO DI ANALISI

Adobe Acrobat Reader necessario per una visualizzazione affidabile,
stampa e commenta sui documenti PDF

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 113ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 10ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

La Santa Cruz Biotechnology, Inc. è un leader mondiale nello sviluppo di prodotti per il mercato della ricerca biomedica. Chiamaci al numero gratuito 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. Tutti i diritti riservati. "Santa Cruz Biotechnology", ed il logo Santa Cruz Biotechnology, Inc."Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", il logo San Juan Ranch, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", ed "EZ Touch" sono marchi registrati dalla Santa Cruz Biotechnology, Inc.
Tutti i marchi sono proprietà dei rispettivi proprietari.